BRPI1014314A2 - derivado de tiopiridina, e, composição farmacêutica. - Google Patents

derivado de tiopiridina, e, composição farmacêutica.

Info

Publication number
BRPI1014314A2
BRPI1014314A2 BRPI1014314A BRPI1014314A BRPI1014314A2 BR PI1014314 A2 BRPI1014314 A2 BR PI1014314A2 BR PI1014314 A BRPI1014314 A BR PI1014314A BR PI1014314 A BRPI1014314 A BR PI1014314A BR PI1014314 A2 BRPI1014314 A2 BR PI1014314A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
thiopyridine
derivative
thiopyridine derivative
pharmaceutical
Prior art date
Application number
BRPI1014314A
Other languages
English (en)
Inventor
Ito Masaharu
Tsujii Masahiko
Yamamoto Masaichi
Hamazaki Mitsunori
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Publication of BRPI1014314A2 publication Critical patent/BRPI1014314A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
BRPI1014314A 2009-04-09 2010-04-08 derivado de tiopiridina, e, composição farmacêutica. BRPI1014314A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009094742 2009-04-09
PCT/JP2010/002561 WO2010116740A1 (ja) 2009-04-09 2010-04-08 ピリジンチオ誘導体及びそれを含有する抗ヘリコバクター・ピロリ作用を有する医薬組成物

Publications (1)

Publication Number Publication Date
BRPI1014314A2 true BRPI1014314A2 (pt) 2019-09-24

Family

ID=42936034

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014314A BRPI1014314A2 (pt) 2009-04-09 2010-04-08 derivado de tiopiridina, e, composição farmacêutica.

Country Status (11)

Country Link
US (1) US20120041030A1 (pt)
EP (1) EP2420500A4 (pt)
JP (1) JP5543432B2 (pt)
KR (1) KR101353572B1 (pt)
CN (1) CN102378761A (pt)
AU (1) AU2010235726B2 (pt)
BR (1) BRPI1014314A2 (pt)
CA (1) CA2756104C (pt)
MX (1) MX2011010663A (pt)
RU (1) RU2484089C1 (pt)
WO (1) WO2010116740A1 (pt)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
JPS6150979A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
JPH0720865B2 (ja) 1989-02-10 1995-03-08 武田薬品工業株式会社 抗菌剤
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
JPH0348680A (ja) 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
JP2798588B2 (ja) 1992-08-21 1998-09-17 エーザイ株式会社 抗菌剤
KR0142815B1 (ko) * 1994-12-02 1998-07-15 정도언 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
RU2142459C1 (ru) * 1994-06-10 1999-12-10 Бык Гульден Ломберг Хемише Фабрик Гмбх Тиопиридины для борьбы с бактериями helicobakter
DE69519581T2 (de) 1994-08-30 2001-05-31 Teikoku Chemical Industry Co., Ltd. Guanidylmethyl cyclohexancarbonsäure ester derivate
US6444703B1 (en) 1995-12-22 2002-09-03 Teikoku Chemical Industries Co., Ltd. Cyclohexane carbocyclic ester derivative and cyclodextrin complex and composition for treatment of helicobacter pylori infections
MX2009006638A (es) * 2006-12-18 2009-07-02 Arigen Pharmaceuticals Inc Agente para erradicar helicobacter pylori que tiene actividad inhibidora sobre la secrecion de acido gastrico.

Also Published As

Publication number Publication date
KR20120008493A (ko) 2012-01-30
EP2420500A1 (en) 2012-02-22
US20120041030A1 (en) 2012-02-16
AU2010235726A1 (en) 2011-09-22
RU2011145284A (ru) 2013-05-20
CA2756104C (en) 2013-01-22
RU2484089C1 (ru) 2013-06-10
EP2420500A4 (en) 2012-09-05
JP5543432B2 (ja) 2014-07-09
CA2756104A1 (en) 2010-10-14
JPWO2010116740A1 (ja) 2012-10-18
WO2010116740A1 (ja) 2010-10-14
KR101353572B1 (ko) 2014-01-22
CN102378761A (zh) 2012-03-14
MX2011010663A (es) 2011-10-28
AU2010235726B2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
HRP20150107T1 (xx) Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
BRPI1010301A2 (pt) composição.
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BRPI0911618A2 (pt) antagonistas da via hedgehog de ftalazina dissubstituída.
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI1016190A2 (pt) compostos farmacêuticos.
BRPI1007811A2 (pt) nacela de turborreator, e, turborreator
BRPI1011620A2 (pt) composição, composto, e, método de diluição.
BR112012003151A2 (pt) composição de revestimento, e, método.
BRPI1014388A2 (pt) preparação de sólido.
BRPI1011460A2 (pt) Composição desinfetante.
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI0922286A2 (pt) composto de quinolona e composição farmacêutica.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: ARIGEN PHARMACEUTICALS, INC. (JP)

B25A Requested transfer of rights approved

Owner name: LINK GENOMICS, INC. (JP)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.